We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The World Health Organization (WHO) has donated a consignment of 155,000 courses of the newly approved atemisinin-based combination therapy to Liberia's Ministry of Health and Social Welfare for malaria treatment.
Scientists at the U.S. Centers for Disease Control and Prevention (CDC) have released genetic blueprints for over 650 genes of influenza viruses into a database accessible to researchers worldwide.
The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has established a panel and a forum, jointly sponsored by the MHRA and the Association of the British Pharmaceutical Industry, to address future challenges in the regulation of pharmaceuticals.
Novartis plans to appeal the Indian Patent Controller's decision to reject its patent application for Gleevec (imatinib mesylate) today in the Chennai High Court.
MerLion Pharmaceuticals Pte Ltd (MerLion) of Singapore, the world's leading natural products-based drug discovery company, announces that it has completed a merger by exchange of shares with Combinature Biopharm AG (Berlin, Germany) and Athelas SA (Geneva, Switzerland).
Claris Lifesciences Ltd (Claris), an Indian pharmaceutical company
with global presence, will launch Propofol injections, under the brand Profol, a powerful narcotic analgesic, in Germany and other European countries.
Merck Frosst is making GARDASIL (quadrivalent human papillomavirus (types 6, 11, 16, 18 recombinant vaccine) available to physicians and pharmacists across Canada.
The Myanmar government has blacklisted eight private companies including a well-known Indian pharmaceutical company for breaching trading regulations, a newspaper reported.
Teva Pharmaceutical Industries Ltd. announced that AZILECT (rasagiline tablets), the first once daily oral treatment for Parkinson's disease (PD), has just been approved by Health Canada.